SCHEMBL29552398

SCHEMBL29552398

O=C(O)c1nnc(Cl)cc1Nc1ccc(N2CCOCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.54
▸ JAK1 P23458 1/20 0.54
▸ TYK2 P29597 1/20 0.54
▸ JAK3 P52333 1/20 0.54
▸ MAPT P10636 6/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ MCL1 Q07820 1/20 0.47
▸ MAPKAPK2 P49137 1/20 0.47
▸ DGAT1 O75907 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ PIM1 P11309 1/20 0.45
▸ MAPK10 P53779 2/20 0.45
▸ MAPK9 P45984 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ MAPK8 P45983 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359240 0.87 JAK2 (0.52) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29922581 0.87 JAK2 (0.52) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29552999 0.85 TYK2 (0.57) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29552260 0.85 MAPT (0.52) MAPTSMN1; SMN2LMNAHTTDGAT1
SCHEMBL29552183 0.80 TYK2 (0.85) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29553126 0.77 SYK (0.41) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29552160 0.76 L3MBTL1 (0.46) JAK2JAK1TYK2JAK3MAPKAPK2
SCHEMBL29552492 0.75 SYK (0.46) MAPTMEN1KMT2ALMNAMAPKAPK2
SCHEMBL5027838 0.74 MAPK9 (0.58) JAK2JAK1TYK2JAK3MAPT
SCHEMBL29551843 0.74 SYK (0.41) JAK2JAK1TYK2JAK3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback